KHAN Technology Transfer Fund I (KHAN-I) is an early-stage life sciences venture fund with €70 million under management. It focuses on investing in seed to early-stage companies within the medical, pharmaceutical, and biotechnology sectors, primarily in Europe. The fund is co-managed by Khanu Management and the Max Planck Society.
Focus Areas
Investment Types
Notable Investments
